Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-968-4 | CAS number: 7782-89-0
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
Data source
Reference
- Reference Type:
- review article or handbook
- Title:
- Hommel Merkblatt No. 2395
- Author:
- Hommel, G.
- Year:
- 2 009
- Bibliographic source:
- Handbuch der gefährlichen Güter © by Springer-Verlag Berlin Heidelberg 2007 - Query date: 2016-04-19
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Data from collection of data, thus no data about the method was available.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Lithium amide
- EC Number:
- 231-968-4
- EC Name:
- Lithium amide
- Cas Number:
- 7782-89-0
- Molecular formula:
- H2LiN
- IUPAC Name:
- lithium amide
- Test material form:
- solid
Constituent 1
Results and discussion
In vivo
Results
- Irritation parameter:
- overall irritation score
- Remarks on result:
- positive indication of irritation
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (corrosive) based on GHS criteria
- Conclusions:
- Lithium amide causes severe skin burns and eye damage.
- Executive summary:
Based on the descriptions in the Hommel handbook, lithium amide causes severe skin burns and eye damage. There is also a risk of irreversible damage of the eyes (e.g. blindness). Lung and larynx edema could also occur even with a delay of 2 days.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
